Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
BioTech
Pharmaceuticals
About Investor
Nassim Usman is the Chief Executive Officer & President of Totus Medicines and a Venture Partner at Morgenthaler Ventures. He focuses on biotechnology and pharmaceuticals from Seed through Series B, with a typical investment range of $100K–$5.0M. His prior roles include CEO of Catalyst Biosciences and senior leadership at Sirna Therapeutics/Ribozyme Pharmaceuticals.
Previous investments
Principia Biopharma
15M |2015
50M |2014
13M |2012
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP